Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on Energizer Holdings, Raises Price Target to $33

Morgan Stanley analyst Dara Mohsenian maintains Energizer Holdings (NYSE:ENR) with a Equal-Weight and raises the price target from $32 to $33.
byBenzinga Newsdesk
November 16, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Dara Mohsenian maintains Energizer Holdings (NYSE:ENR) with a Equal-Weight and raises the price target from $32 to $33.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Cogent Biosciences Announced Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosisl; Announced 89% ORR in TKI-therapy Naïve Patients; 73% ORR in All Evaluable Patients with 27-wee…

By Charles Gross
December 11, 9:20 PM
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced positive updated clinical data from its ongoing Phase 2 APEX clinical trial evaluating the selective KIT D816V inhibitor bezuclastinib in patients with advanced systemic m

COGT